NCT01850849View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics in AD Subjects and Healthy Subjects of Cutaneous Application of LEO 39652 Cream

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

December 31, 2014

Conditions
Atopic Dermatitis
Interventions
DRUG

LEO 39652 cream

DRUG

cream vehicle

Trial Locations (2)

LS2 9LH

Covance Clinical Research Unit, Hyde Street, Leeds, UK, Leeds

L7 8XP

Covance Royal Liverpool Clinical Research Unit, Liverpool

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY

NCT01850849 - Safety, Tolerability and Pharmacokinetics in AD Subjects and Healthy Subjects of Cutaneous Application of LEO 39652 Cream | Biotech Hunter | Biotech Hunter